Samantha Wallner Selected Research

Reactive Oxygen Species (Oxygen Radicals)

6/2014

Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samantha Wallner Research Topics

Disease

1	Neuromuscular Diseases (Neuromuscular Disease) 01/2019
1	Hemolysis 06/2014
1	Anemia 06/2014
1	Splenomegaly 06/2014
1	Thalassemia 06/2014
1	beta-Thalassemia (Cooley's Anemia) 06/2014
1	Iron Overload 06/2014

Drug/Important Bio-Agent (IBA)

2	LigandsIBA 01/2019 - 06/2014
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 06/2014
1	FollistatinIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Activin Receptors (Activin Receptor)IBA 06/2014
1	IronIBA 06/2014
1	luspaterceptIBA 06/2014
1	activin receptor type II-BIBA 06/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2014
1	Erythropoietin FDA Link 06/2014
1	GlobinsIBA 06/2014